Copyright
©The Author(s) 2017.
World J Clin Pediatr. May 8, 2017; 6(2): 110-117
Published online May 8, 2017. doi: 10.5409/wjcp.v6.i2.110
Published online May 8, 2017. doi: 10.5409/wjcp.v6.i2.110
Table 1 Baseline characteristics of rapid and slow conversion groups
| Rapid conversion groupa (n = 21) | Slow conversion groupb (n = 21) | P value | |
| Age, yr (median, IQR) | 1 (0.3-3.5) | 2 (0.8-4) | 0.95 |
| Gender, male (%) | 14 (67%) | 9 (43%) | 0.21 |
| Weight, kg (median, IQR) | 10 (5.5-14.3) | 9.6 (6.8-15.9) | 0.88 |
| PRISM III (mean ± SD) | 11.4 ± 9 | 16.1 ± 9.9 | 0.13 |
| Admitting diagnosis, n (%) | 1 | ||
| ARDS/acute lung injury | 14 (67) | 14 (67) | |
| Other (sepsis, seizures) | 7 (33) | 7 (33) | |
| Pre-existing tracheostomy, n (%) | 6 (29) | 6 (29) | 1 |
| Duration of IV fentanyl infusion prior to initiation of enteral methadone, d (median, IQR) | 9 (8-14) | 10 (8-21) | 0.48 |
| Maximum dose of IV fentanyl infusion, μg/kg per hour (median, IQR) | 6 (4-7) | 6.75 (4-9.25) | 0.41 |
| Cumulative dose of IV fentanyl infusion at time of initiation of enteral methadone, mg/kg (median, IQR) | 1.48 (1.11-1.92) | 1.64 (1.03-1.98) | 0.49 |
| Concomitant sedative and analgesic infusions | 0.61 | ||
| Benzodiazepine, n (%) | 18 (86) | 20 (95) | |
| Ketamine, n (%) | 0 (0) | 0 (0) | |
| Dexmedetomidine, n (%) | 0 (0) | 0 (0) |
Table 2 Conversion from intravenous fentanyl infusion to enteral methadone in rapid and slow conversion groups
| Rapid conversion groupa (n = 21) | Slow conversion groupb (n = 21) | P value | |
| Dose of IV fentanyl infusion at initiation of enteral methadone, μg/kg per hour (median, IQR) | 4 (3-4) | 4.5 (3.6-7) | 0.23 |
| Adjustments in scheduled enteral methadone dose | < 0.05 | ||
| Increase in dose | 15 | 33 | |
| Decrease in dose | 17 | 3 | |
| Opioid rescues in first 96 h of transition per patient (median, IQR) | 3 (1-7) | 12 (4-17) | < 0.05 |
| 0-24 h | 0 (0-2) | 3 (0-4) | < 0.05 |
| 24-48 h | 1 (0-2) | 2 (1-6) | 0.02 |
| 48-72 h | 0 (0-1) | 1 (1-6) | 0.01 |
| 72-96 h | 0 (0-2) | 2 (0-4) | 0.12 |
| Opioid rescues in first 96 h of transition by agent | < 0.05 | ||
| Morphine | 44 | 51 | |
| Fentanyl | 51 | 210 | |
| Concomitant medications administered in first 96 h of transition (number of administrations) | 0.6 | ||
| Benzodiazepines | 32 | 40 | |
| Clonidine | 5 | 3 | |
| Barbiturates | 2 | 8 | |
| NSAIDS | 2 | 2 | |
| Neuromuscular blockers | 4 | 6 | |
| Acetaminophen | 9 | 10 |
Table 3 Clinical outcomes in rapid and slow conversion groups
Table 4 Example of dose conversion from intravenous fentanyl infusion directly to enteral methadone
| A 10-kg child is receiving IV fentanyl infusion of 5 mcg/kg per hour. The total daily fentanyl dose is 5 μg/kg per hour × 24 h = 1.2 mg/d |
| Dose conversion ratio - methadone:fentanyl = 2.5 (rounded up from 2.3 observed in rapid conversion group in the present study that converted from IV fentanyl infusion directly to enteral methadone within 48 h) based on potency, half-life and enteral bioavailability |
| Total daily dose of enteral methadone = 2.5 × 1.2 mg/d = 3 mg/d administered in 2 divided doses, i.e., 1.5 mg dosed every 12 h |
| Following the second dose of enteral methadone, the IV fentanyl infusion is decreased by 50% to 2.5 mcg/kg per hour |
| Following the third dose of enteral methadone, the IV fentanyl infusion is decreased again by 50% to 1.25 mcg/kg per hour |
| Following the fourth dose of enteral methadone, the IV fentanyl infusion is discontinued |
- Citation: Srinivasan V, Pung D, O’Neill SP. Conversion from prolonged intravenous fentanyl infusion to enteral methadone in critically ill children. World J Clin Pediatr 2017; 6(2): 110-117
- URL: https://www.wjgnet.com/2219-2808/full/v6/i2/110.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v6.i2.110
